REFERENCE
Kaper J, van Schayck CP, Severens L.The cost-effectiveness of antidepressants for smoking cessation in patients with COPD. European Respiratory Journal Supplement 28 (Suppl. 50): 801 abstr. 4635, Sep 2006
Rights and permissions
About this article
Cite this article
Bupropion SR appears to be the most cost-effective smoking cessation therapy compared with nortriptyline and placebo,. Pharmacoecon. Outcomes News 514, 8 (2006). https://doi.org/10.2165/00151234-200605140-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605140-00019